Sign In
Buy IMMP
$0.394
+0.0167 (+4.43%)
At Close: Jun 23, 2026
Immutep Completes Recruitment for Stage 1 of Part B in TACTI-002 Study
12:00pm, Tuesday, 18'th Aug 2020
* 23 patients with second line Non-Small Cell Lung Cancer (NSCLC) participating in Stage 1, Part B * Total of 87 patients out of up to 109 patients (80%) are enrolled and participating in the trial
Immutep Issues Newsletter Update to Shareholders
12:00pm, Monday, 17'th Aug 2020
LAG-3 Therapeutic Landscape Overview Formatted version of this update available on the Company’s website www.immutep.comSYDNEY, Australia, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM
Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
12:00pm, Tuesday, 11'th Aug 2020
SYDNEY, Australia, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for
A Look At Immutep's (ASX:IMM) Share Price Returns
09:36pm, Tuesday, 21'st Jul 2020
Immutep Limited (ASX:IMM) has rebounded strongly over the last week, with the share price soaring 45%. But don't envy...
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
11:30am, Wednesday, 15'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) * Altimmune Inc (NASDAQ: ALT) (priced its $115 millio
Immutep Announces United States Patent Grant for IMP701 Antibody
11:00pm, Tuesday, 14'th Jul 2020
SYDNEY, Australia, July 15, 2020 -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces the grant of patent no. 10,711,060 entitled “Antibody.
Immutep Completes Recruitment for Part A of Phase II TACTI-002 Study
12:00pm, Monday, 29'th Jun 2020
Completes recruitment of patients with first line Non-Small Cell Lung Cancer (NSCLC)81 patients out of up to 109 now participating across the trial, with recruitment continuing.
Immutep receives A$1,437,826 R&D Tax Incentive
12:00pm, Monday, 22'nd Jun 2020
SYDNEY, Australia, June 22, 2020 -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased to announce that it has received a A$1,437,826 cash rebate.
Immutep Surges In Pre-Market On Positive Efti Cancer Data
11:40am, Monday, 01'st Jun 2020
Shares in Immutep (IMMP) are surging 10% in Monday’s pre-market trading after the company announced first interim data from its ongoing INSIGHT-004 Phase I clinical trial at the 2020 American Societ
Immutep Announces Improving Data from the Phase II TACTI-002 Study
11:40pm, Sunday, 31'st May 2020
Presented at ASCO 2020 Annual Meeting First complete response reported in 2nd line head and neck squamous cell carcinoma (HNSCC)Improving Overall Response Rate (iORR) in HNSCC,.
Immutep Reports First Results from INSIGHT-004 Study
11:30pm, Sunday, 31'st May 2020
First data from this collaboration study with Merck KGaA, Darmstadt, Germany, and Pfizer Inc and sponsor, IKF, presented at ASCOEncouraging early activity signals in a variety.
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
11:22am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
Immutep Receives US$2.4 Million R&D Tax Incentive from French Government
12:14am, Friday, 29'th May 2020
SYDNEY, Australia, May 29, 2020 -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for.
How Hedge Funds Traded Immutep Limited (IMMP) During The Crash
06:01pm, Thursday, 28'th May 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Immutep Global Webcast to Present New Data from 2020 ASCO Annual Meeting
12:13am, Wednesday, 27'th May 2020
SYDNEY, Australia, May 27, 2020 -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) will host a global webcast on Tuesday 2 June 2020 at 7.30am, Australia Eastern Standard Time (AEST).
